OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2021
(6)
2022
(5)
2023
(2)
2017
(2)
2025
(1)
2024
(1)
2020
(1)
2015
(1)
2014
(1)
2013
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Convergent genetic and expression data implicate immunity in Alzheimer's disease.
Not available
S-EPMC4672734
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
Not available
S-EPMC3664945
|
biostudies-literature
Cite
Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.
Not available
S-EPMC6685441
|
biostudies-literature
Cite
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
Not available
S-EPMC8184987
|
biostudies-literature
Cite
New insights into the genetic etiology of Alzheimer's disease and related dementias.
Not available
S-EPMC9005347
|
biostudies-literature
Cite
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Not available
S-EPMC11873788
|
biostudies-literature
Cite
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets